Mutation Detection Kits In Genome Editing Industry Projected to Experience Accelerated Growth by 2029

Mutation Detection Kits In Genome Editing Industry


Save 20% on All Global Market Reports With Code ONLINE20 – Gain Insights Into Tariffs, Inflation, and Industry Trends


What Is the Expected Market Growth Rate for the Mutation Detection Kits In Genome Editing Market?
The mutation detection kits in the genome editing market size has grown rapidly in recent years. It will grow from $1.01 billion in 2024 to $1.14 billion in 2025 at a compound annual growth rate (CAGR) of 13.4%. The growth in the historic period can be attributed to growing research in genetic disorders, increasing government funding for genomics, rising academic and clinical research collaborations, growing availability of advanced molecular biology tools, and rising investments by biotech companies.

The mutation detection kits in the genome editing market size are expected to see rapid growth in the next few years. It will grow to $1.86 billion in 2029 at a compound annual growth rate (CAGR) of 13.1%. The growth in the forecast period can be attributed to rising adoption of autonomous mobile robots (AMRs), growing focus on supply chain visibility, increasing investment in digital twin technologies, growing demand for real-time asset tracking, and increasing adoption of industrial automation. Major trends in the forecast period include advancement in real-time location systems (RTLS), innovation in AI-powered asset tracking, integration of RFID with IoT platforms, advancement in ultra-wideband (UWB) technology, and integration of digital twin solutions for industrial automation.

Claim your free report sample now:

What Are the Major Drivers Influencing the Mutation Detection Kits In Genome Editing Market?
The rising prevalence of genetic disorders is expected to propel the growth of the mutation detection kits in the genome editing market going forward. Genetic disorders refer to diseases or conditions caused by abnormalities in an individual's DNA, which may be inherited from parents or occur due to new genetic mutations. The rise in genetic disorders is driven by greater awareness and advanced diagnostic technologies, enabling earlier and more accurate identification of conditions, resulting to higher reported prevalence rates. Genome editing mutation detection kits help address genetic disorders by accurately identifying disease-causing gene mutations, enabling targeted research and the development of precise therapeutic interventions. For instance, in May 2024, according to the National Health Service, a UK-based government department, in England, approximately 17,000 people live with sickle cell disease, an inherited blood disorder, with around 250 new cases diagnosed each year. Therefore, the rising prevalence of genetic disorders is driving the growth of the mutation detection kits in the genome editing market.

Which Are the Leading Segments in the Mutation Detection Kits In Genome Editing Market by Revenue?
The mutation detection kits in genome editing market covered in this report is segmented

1) By Product Type: Reagents, Kits, Software Solutions
2) By Technology: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Transcription Activator-Like Effector Nucleases Or Meganuclease-TAL Effector Nucleases (TALENs/MegaTALs), Zinc Finger Nucleases (ZFN), Other Technologies
3) By Application: Research, Clinical Diagnostics, Drug Development, Other Applications
4) By End Use: Academic Institutions, Hospitals And Diagnostic Centers, Biotechnology Companies

Subsegments:
1) By Reagents: Deoxyribonucleic Acid Polymerases (DNA) Polymerases, Nucleases, Buffers And Enzymes, Fluorescent Dyes And Probes, Primers And Oligonucleotides
2) By Kits: Polymerase Chain Reaction (PCR)-Based Mutation Detection Kits, Next-Generation Sequencing-Based Mutation Analysis Kits, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Mutation Validation Kits, Gel Electrophoresis-Based Detection Kits
3) By Software Solutions: Mutation Analysis And Visualization Tools, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Off-Target Prediction Software, Genomic Alignment and Annotation Software, Data Interpretation Platforms For Next-Generation Sequencing, Cloud-Based Bioinformatics Platforms


Which Trends Are Expected to Redefine the Mutation Detection Kits In Genome Editing Market Landscape?
Major companies operating in the mutation detection kits in the genome editing market are focusing on developing advanced products such as ultrasensitive multiplexed assays to enhance accuracy, speed, and sensitivity in detecting genetic mutations. Ultrasensitive multiplexed assays are advanced diagnostic tests that can detect and measure multiple genetic mutations simultaneously at very low levels, helping researchers and clinicians achieve faster, more accurate, and more comprehensive mutation analysis for better disease diagnosis and treatment monitoring. For instance, in April 2024, Bio-Rad Laboratories Inc., a US-based research company, launched the ddPLEX ESR1 Mutation Detection Kit, an ultrasensitive multiplexed digital PCR assay designed for breast cancer mutation detection. This kit enables simultaneous identification and precise quantification of seven ESR1 mutations with an analytical sensitivity down to 0.01% variant allele fraction, supporting both plasma and tissue sample analysis. Such innovations exemplify the industry’s commitment to improving diagnostic accuracy and enabling more effective disease monitoring and personalized treatment strategies.

Who Are the Leading Players in the Mutation Detection Kits In Genome Editing Market?
Major companies operating in the mutation detection kits in genome editing market are F. Hoffmann-La Roche Ltd, Merck KGaA, Thermo Fisher Scientific Inc., QIAGEN N.V., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Integrated DNA Technologies Inc., GenScript Biotech Corporation, Takara Bio Inc., Promega Corporation, Analytik Jena AG, Twist Bioscience Corporation, New England Biolabs Inc., Applied Biological Materials Inc., Synthego Corporation, Cell Signaling Technology Inc., BioVision Inc., Creative Biogene Corporation.

Get the full mutation detection kits in genome editing market report here:

What Are the Opportunities and Challenges for Mutation Detection Kits In Genome Editing Market Across Regions?
North America was the largest region in the mutation detection kits in genome editing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mutation detection kits in genome editing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company


Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267



Follow Us On:

Comments